CD55 (K142) Peptide

Avoidance by host tissues of attack by autologous complement proteins is dependent in part on the activities of membrane regulatory factors. One molecule involved in this control is a 70 kD glycoprotein termed decay-accelerating factor (DAF), or CD55. Interruption by CD55 of the complement sequence at an early step in activation effectively halts progression of the cascade and prevents consequent cell injury. In man, CD55 is expressed on the plasma membrane of all cell types that are in intimate contact with plasma complement proteins.

Prices direct from Bioworld Technology, Inc.

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

BS3842P

Applications

BNI

Form

1 mg/ml in DI water.

Purity

Synthetic peptide CD55 (K142). (Note: the amino acid sequence is proprietary). The purity is > 98%.

Swiss Prot

P08174

Storage Temp

Store at 4 degree C short term. Aliquot and store at -20 degree C long term. Avoid freeze-thaw cycles.

Additional Info

This peptide can be used with studies using BS3842 CD55 (K142) pAb.

Alternative Names

CR; Cromer Blood Group antigen; DAF; Decay Accelerating Factor for Complement; TC; CD 55; CD55 antigen; CD55 Cromer blood group system; CD55 molecule; Complement decay accelerating factor; Cromer blood group system